Cargando…

Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review

Subacute cutaneous lupus erythematosus (SCLE) is characterized by particular cutaneous manifestations such as non-scaring plaques mainly in sunlight exposed parts of the body along with specific serum autoantibodies (i.e. antinuclear antibodies (ANA), Ro/SSa, La/SSb). It is considered either idiopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarkavelis, George, Kollas, Aristomenes, Kampletsas, Eleftherios, Vasiliou, Vasilis, Kaltsonoudis, Evripides, Drosos, Alexandros, Khaled, Hussein, Pavlidis, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328027/ https://www.ncbi.nlm.nih.gov/pubmed/28275510 http://dx.doi.org/10.1016/j.jare.2016.04.001

Ejemplares similares

Testicular Signet-Ring Cell Metastasis from a Carcinoma of Unknown Primary Site: A Case Report and Literature Review
por: Kollas, Aristomenes, et al.
Publicado: (2016)

Biologic Therapies and Autoimmune Phenomena
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Dermatomyositis sine myositis – Case presentation
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2017)

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature
por: Kastrisiou, Myrto, et al.
Publicado: (2018)

Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020)

The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor
por: Pelechas, Eleftherios, et al.
Publicado: (2017)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Bone and soft tissue sarcomas during pregnancy: A narrative review of the literature
por: Zarkavelis, George, et al.
Publicado: (2016)

Lung cancer during pregnancy: A narrative review
por: Mitrou, Sotirios, et al.
Publicado: (2016)

A mini review on pregnant mothers with cancer: A paradoxical coexistence
por: Mitrou, Sotirios, et al.
Publicado: (2016)

Chemotherapy Associated Ovarian Failure
por: Mauri, Davide, et al.
Publicado: (2020)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Precautions for Patients Taking Aromatase Inhibitors
por: Heery, Mary, et al.
Publicado: (2020)

Aromatase inhibitors in stimulated IVF cycles
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Aromatase inhibitors in male sex
por: Singh, Santosh Kumar
Publicado: (2013)

Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)

Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2014)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

The effects of aromatase inhibitors on lipids and thrombosis
por: Bundred, N J
Publicado: (2005)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Aromatase inhibitors in post-menopausal endometriosis
por: Polyzos, Nikolaos P, et al.
Publicado: (2011)

Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010)

Understanding the mechanisms of aromatase inhibitor resistance
por: Miller, William R, et al.
Publicado: (2012)

Use of aromatase inhibitors in practice of gynecology
por: Usluogullari, Betul, et al.
Publicado: (2015)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

The Role of Aromatase Inhibitors in Male Prolactinoma
por: Akirov, Amit, et al.
Publicado: (2023)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
por: Zava, David T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5cuv9nsa3gvilk7j2nc154ohn